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ABSTRACT
Background: Dietary protein ingestion stimulates muscle protein synthesis by providing amino acids to the muscle.
The magnitude and duration of the postprandial increase in muscle protein synthesis rates are largely determined by
dietary protein digestion and amino acid absorption kinetics.
Objective: We assessed the impact of protein type, protein dose, and age on dietary protein digestion and amino acid
absorption kinetics in vivo in humans.
Methods: We included data from 18 randomized controlled trials with a total of 602 participants [age: 53 ± 23 y; BMI
(kg/m2): 24.8 ± 3.3] who consumed various quantities of intrinsically L-[1-13C]-phenylalanine–labeled whey (n = 137),
casein (n = 393), or milk (n = 72) protein and received intravenous infusions of L-[ring-2H5]-phenylalanine, which allowed
us to assess protein digestion and phenylalanine absorption kinetics and the postprandial release of dietary protein–
derived phenylalanine into the circulation. The effect of aging on these processes was assessed in a subset of 82 young
(aged 22 ± 3 y) and 83 older (aged 71 ± 5 y) individuals.
Results: A total of 50% ± 14% of dietary protein–derived phenylalanine appeared in the circulation over a 5-h
postprandial period. Casein ingestion resulted in a smaller (45% ± 11%), whey protein ingestion in an intermediate
(57% ± 10%), and milk protein ingestion in a greater (65% ± 13%) fraction of dietary protein–derived phenylalanine
appearing in the circulation (P < 0.001). The postprandial availability of dietary protein–derived phenylalanine in the
circulation increased with the ingestion of greater protein doses (P < 0.05). Protein digestion and phenylalanine
absorption kinetics were attenuated in older when compared with young individuals, with 45% ± 10% vs. 51% ± 14%
of dietary protein–derived phenylalanine appearing in the circulation, respectively (P = 0.001).
Conclusions: Protein type, protein dose, and age modulate dietary protein digestion and amino acid absorption
kinetics and subsequent postprandial plasma amino acid availability in vivo in humans. These trials were registered
at clinicaltrials.gov as NCT00557388, NCT00936039, NCT00991523, NCT01317511, NCT01473576, NCT01576848,
NCT01578590, NCT01615276, NCT01680146, NCT01820975, NCT01986842, and NCT02596542, and at http://www.tr
ialregister.nl as NTR3638, NTR3885, NTR4060, NTR4429, and NTR4492. J Nutr 2020;00:1–10.
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Introduction
Dietary protein ingestion stimulates muscle protein synthesis
rates by providing amino acids to the muscle (1, 2). Various
factors have been shown to influence the postprandial muscle
protein synthetic response, such as dietary protein digestion and
amino acid absorption (3, 4), splanchnic amino acid retention
(5, 6), plasma amino acid availability, muscle perfusion and
the delivery of amino acids to the muscle (7, 8), uptake of
amino acids by the muscle (9, 10), and intramuscular signaling
that results in the activation of the muscle protein synthetic
machinery (11, 12). Consequently, the ingested protein amount
(13–15), source (16–18), and type (3, 19, 20) differentially
impact plasma amino acid profiles and, as such, the magnitude
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and duration of the postprandial increase in muscle protein
synthesis rates.
Ingestion of whey protein has been shown to strongly
increase muscle protein synthesis rates over a short(er) time
frame, whereas casein ingestion may stimulate muscle protein
synthesis rates to a moderate extent for a more prolonged
time period (3). The divergent postprandial muscle protein
synthetic responses seem to be, at least partly, attributed
to the more rapid protein digestion after ingestion of whey
compared with micellar casein (3, 4). Although whey protein
and casein have been studied extensively (3, 4, 14–17, 19–
22), less is known regarding the dietary protein digestion and
amino acid absorption kinetics of intact bovine milk protein,
providing both whey and casein in a ratio of ∼20:80. Besides
protein type, ingesting a greater amount of protein generally
results in a dose-dependent stimulation of muscle protein
synthesis until a plateau is reached (14, 15, 23, 24). Whether
the protein dose affects the postprandial release of dietary
protein–derived amino acids into the circulation and whether
the dose–response in postprandial amino acid availability
is specific for each type of protein have not been clearly
established.
Another factor determining the muscle protein synthetic
response to protein ingestion is age. Older age is associated with
a lower muscle protein synthetic response to food ingestion, also
referred to as anabolic resistance (11, 25). Anabolic resistance
to protein intake is believed to be one of the factors responsible
for the loss of muscle mass observed with increasing age (11,
25, 26). It has been suggested that impairments in dietary
protein digestion and amino acid absorption kinetics, resulting
in increased splanchnic amino acid retention and a blunted
postprandial increase in circulating amino acids, may contribute
to age-related anabolic resistance of muscle protein synthesis
rates. While some studies suggest greater splanchnic amino
acid retention following amino acid administration in older
compared with younger adults (5, 6), other studies have failed to
confirm those findings following the ingestion of a single bolus
of protein (27, 28). Thus, it remains unclear whether protein
digestion and amino acid absorption kinetics are impaired with
aging.
Over the past decade, we have conducted 18 randomized
controlled trials (RCTs) in which we applied intravenous
infusions of l-[ring-2H5]-phenylalanine in combination with
the ingestion of intrinsically l-[1-13C]-phenylalanine–labeled
protein to assess dietary protein digestion and phenylala-
nine absorption kinetics, as well as the subsequent plasma
availability of dietary protein–derived phenylalanine in young
and older individuals ingesting varying amounts of casein,
whey, or milk protein concentrate (20, 21, 24, 27, 29–48).
Combining data from 18 RCTs, with >600 participants who
underwent the same experimental procedures, provided us
with an ideal opportunity to assess the impact of protein
type (i.e., casein, whey, and milk protein), protein dose,
and age on protein digestion and phenylalanine absorption
Supported by Top Institute Food and Nutrition, which is a public–private
partnership on precompetitive research in food and nutrition.
Author disclosures: LJCvL and LBV have received research grants, consulting
fees, speaking honoraria, or a combination of these, from Friesland Campina,
Nutricia Research, and PepsiCo. The other authors report no conflicts of interest.
The industrial partners contributed to the project through regular discussions.
Address correspondence to LJCvL (e-mail: l.vanloon@maastrichtuniversity.nl).
Abbreviations used: BM, body mass; Ra, rate of appearance; RCT, randomized
controlled trial; T, tertile.
TABLE 1 Characteristics of participants who consumed
intrinsically labeled whey, casein, or milk protein1
Whey (n = 137) Casein (n = 393) Milk (n = 72)
Dose
g 23 ± 5a 24 ± 7a,b 26 ± 11b
g/kg BM 0.29 ± 0.08a 0.32 ± 0.10a,b 0.33 ± 0.13b
g/kg LBM 0.38 ± 0.11a 0.40 ± 0.12a,b 0.43 ± 0.18b
Age, y 54 ± 20 52 ± 24 51 ± 22
Men/women, n/n 125/12 393/0 72/0
Height, m 1.77 ± 0.07 1.78 ± 0.07 1.79 ± 0.07
BM, kg 80.3 ± 15.7a 77.5 ± 9.1b 78.5 ± 9.3a,b
BMI, kg/m2 25.6 ± 4.5a 24.6 ± 2.8b 24.5 ± 3.4a,b
Fat, % 21.6 ± 5.9a 19.1 ± 4.9b 20.1 ± 5.4a,b
ALM, kg 27.9 ± 5.1 27.2 ± 3.5 26.8 ± 3.7
LBM, kg 61.0 ± 8.8 60.7 ± 6.2 60.3 ± 6.7
HbA1c, % 5.5 ± 0.5a,b 5.7 ± 0.7a 5.4 ± 0.3b
Plasma glucose, mmol/L
Fasting 5.5 ± 0.6a 5.9 ± 1.4b 5.9 ± 0.6b
2 h post–75-g oral-glucose 5.8 ± 1.8a 6.7 ± 3.5b 5.8 ± 1.6a,b
1Values are means ± SDs. Labeled means (in a row) without a common letter differ,
P < 0.05. ALM, appendicular lean mass; BM, body mass; HbA1c, glycated
hemoglobin; LBM, lean body mass.
kinetics, and the subsequent postprandial release of dietary




The present study includes data from 18 previously published RCTs
from our laboratory (20, 21, 24, 27, 29–49). All RCTs were approved
by the Medical Ethics Committee of Maastricht UMC+ and the
procedures followed were in accordance with the latest version
of the Helsinki Declaration. The included studies involved oral
consumption of a single dose of intrinsically l-[1-13C]-phenylalanine–
labeled protein, in combination with a primed, constant l-[ring-2H5]-
phenylalanine infusion to determine dietary protein digestion and
amino acid absorption kinetics and plasma amino acid availability
over ≥3 h. Studies, or study arms, that used hydrolyzed protein or
beef protein were not included in the analysis, which resulted in
the inclusion of 602 participants who consumed various quantities
of intact whey, micellar casein, or milk protein. The majority of
participants were men, with only a few women (n = 12) included
from a recent study in which we showed that dietary protein digestion
and amino acid absorption kinetics do not differ between men and
women (49).
To assess the effects of protein type on dietary protein digestion and
amino acid absorption kinetics and postprandial plasma amino acid
availability, we included data from all 602 participants who consumed
either whey protein (n = 137), casein (n = 393), or milk protein
concentrate (n = 72; see Table 1 for participants’ characteristics). To
investigate the effects of protein dose on dietary protein digestion
and amino acid absorption kinetics and postprandial plasma amino
acid availability, we conducted separate analyses for whey protein and
casein. Only studies that measured protein digestion and amino acid
absorption kinetics for ≥5 h after protein ingestion were included.
This approach resulted in n = 76 for whey protein and n = 359 for
casein. Protein dose was expressed in grams of protein per kilogram
of body mass (BM), and participants were divided in tertiles (T) of
protein dose (see Tables 2 and 3 for participants’ characteristics). The
use of relative protein intakes is preferred over absolute protein intakes
as this takes into account the differences in BM between individuals
(23, 50). Whey protein dose ranged from 0.15 to 0.27 g/kg BM for
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TABLE 2 Characteristics of participants who consumed a low,
medium, or high dose of intrinsically labeled whey protein1
T1 (n = 25) T2 (n = 25) T3 (n = 26)
Dose
g 22 ± 2a 23 ± 2b 24 ± 1b
g/kg BM 0.23 ± 0.04a 0.29 ± 0.01b 0.35 ± 0.04c
g/kg LBM 0.32 ± 0.04a 0.38 ± 0.03b 0.47 ± 0.05c
Age, y 59 ± 13 59 ± 13 52 ± 11
Men/women, n/n 25/0 25/0 14/12
Height, m 1.78 ± 0.08a 1.79 ± 0.08a 1.72 ± 0.05b
BM, kg 99.3 ± 24.3a 79.7 ± 6.6b 68.6 ± 8.6c
BMI, kg/m2 31.4 ± 6.6a 25.0 ± 1.9b 23.0 ± 2.3b
Fat, % 27.4 ± 7.0a 20.9 ± 4.6b 23.3 ± 4.0b
ALM, kg 33.5 ± 4.8a 28.7 ± 2.5b 22.8 ± 3.4c
LBM, kg 69.4 ± 10.3a 61.1 ± 4.4b 50.7 ± 6.8c
HbA1c, % 5.8 ± 0.4a 5.5 ± 0.5a,b 5.3 ± 0.3b
Plasma glucose, mmol/L
Fasting 6.0 ± 0.7a 5.5 ± 0.5b 5.4 ± 0.5b
2 h post–75-g oral-glucose 6.6 ± 2.0a 5.2 ± 1.5b 5.0 ± 1.7b
1Values are means ± SDs. Labeled means (in a row) without a common letter differ,
P < 0.05. Protein dose ranged from 0.15 to 0.27 g/kg BM for T1, 0.28 to 0.30 g/kg
BM for T2, and 0.31 to 0.46 g/kg BM for T3. ALM, appendicular lean mass; BM, body
mass; HbA1c, glycated hemoglobin; LBM, lean body mass; T, tertile.
T1, 0.28 to 0.30 g/kg BM for T2, and 0.31 to 0.46 g/kg BM for
T3. Casein dose ranged from 0.20 to 0.25 g/kg BM for T1, 0.26 to
0.33 g/kg BM for T2, and 0.34 to 0.64 g/kg BM for T3. Finally, for the
comparison between young and older individuals, we included 4 RCTs
that compared young and older individuals all within the RCT. These
4 studies were conducted in healthy young and older men ingesting
35 g (27) or 20 g (32, 35, 42) intrinsically labeled casein, measured
for ≥5 h, and included experimental arms that also involved exercise
(42), carbohydrate co-ingestion (32), or local insulin infusion (35). This
approach yielded data from n = 82 young and n = 83 older individuals
(see Table 4 for participants’ characteristics).
TABLE 3 Characteristics of participants who consumed a low,
medium, or high dose of intrinsically labeled casein1
T1 (n = 120) T2 (n = 120) T3 (n = 119)
Dose
g 20 ± 1a 21 ± 2a 33 ± 7b
g/kg BM 0.24 ± 0.01a 0.28 ± 0.02b 0.44 ± 0.07c
g/kg LBM 0.31 ± 0.02a 0.36 ± 0.04b 0.55 ± 0.11c
Age, y 60 ± 21a 56 ± 24a 46 ± 25b
Men/women, n/n 120/0 120/0 119/0
Height, m 1.79 ± 0.07a 1.76 ± 0.07b 1.78 ± 0.07a,b
BM, kg 84.1 ± 5.4a 73.3 ± 6.7b 73.4 ± 9.4b
BMI, kg/m2 26.5 ± 2.1a 23.7 ± 2.3b 23.3 ± 2.8b
Fat, % 21.1 ± 4.0a 18.5 ± 4.9b 17.0 ± 5.0b
ALM, kg 27.6 ± 2.8a 25.2 ± 2.5b 27.0 ± 3.9a
LBM, kg 64.5 ± 4.8a 57.9 ± 4.2b 58.4 ± 7.0b
HbA1c, % 5.9 ± 0.9a 5.6 ± 0.4b 5.6 ± 0.4b
Plasma glucose, mmol/L
Fasting 6.3 ± 1.9a 5.7 ± 0.8b 5.7 ± 0.7b
2 h post–75-g oral-glucose 7.8 ± 4.7a 6.1 ± 2.4b 6.0 ± 1.5b
1Values are means ± SDs. Labeled means (in a row) without a common letter differ,
P < 0.05. Protein dose ranged from 0.20 to 0.25 g/kg BM for T1, 0.26 to 0.33 g/kg
BM for T2, and 0.34 to 0.64 g/kg BM for T3. ALM, appendicular lean mass; BM, body
mass; HbA1c, glycated hemoglobin; LBM, lean body mass; T, tertile.
TABLE 4 Characteristics of young (age 22 ± 3 y) and older
(age 71 ± 5 y) men who consumed intrinsically labeled casein1
Young (n = 82) Older (n = 83)
Dose
g 22 ± 5 22 ± 5
g/kg BM 0.30 ± 0.07 0.29 ± 0.07
g/kg LBM 0.33 ± 0.04 0.34 ± 0.04
Age, y 22 ± 3 71 ± 5∗
Height, m 1.82 ± 0.07 1.75 ± 0.06∗
BM, kg 74.2 ± 9.1 77.1 ± 9.4∗
BMI, kg/m2 22.4 ± 2.2 25.2 ± 2.6∗
Fat, % 15.2 ± 3.5 20.0 ± 3.7∗
ALM, kg 27.0 ± 3.3 25.6 ± 3.0∗
LBM, kg 60.9 ± 7.3 59.7 ± 6.1
HbA1c, % 5.3 ± 0.3 5.7 ± 0.4∗
Plasma glucose, mmol/L
Fasting 5.1 ± 0.3 5.6 ± 0.5∗
2 h post–75-g oral-glucose 4.5 ± 1.0 6.1 ± 1.6∗
1Values are means ± SDs. ∗Different from young. Age ranged from 18 to 30 y for
young and 60 to 83 y for older men. ALM, appendicular lean mass; BM, body mass;
HbA1c, glycated hemoglobin; LBM, lean body mass.
Infusion trials
Most studies were conducted during the daytime, starting in the
morning after an overnight fast. A few studies were conducted during
the overnight period and started with a standardized dinner 7 h
(36, 43) or 5 h (37, 41, 43, 44) prior to the ingestion of a single bolus of
intrinsically labeled protein. Three of those overnight studies provided
an additional postexercise recovery drink (containing 20 g protein) 2.5 h
prior to the ingestion of intrinsically labeled protein (43–44). On the
day of the trial, participants came to the laboratory by car or public
transport and had a cannula inserted into an antecubital vein for stable
isotope–labeled amino acid infusion. For the daytime studies, a second
cannula was inserted into a dorsal hand vein of the contralateral arm
and placed in a hot-box (60◦C) for arterialized blood sampling (51).
For the overnight studies, the second cannula was inserted into an
antecubital vein of the contralateral arm wrapped in a heated blanket.
After collecting a baseline blood sample, the plasma phenylalanine
pool was primed with a single dose of l-[ring-2H5]-phenylalanine
(2–3.6 μmol/kg), followed by a continuous intravenous l-[ring-2H5]-
phenylalanine (0.045–0.060 μmol · kg−1 · min−1) infusion. After
≥2 h of infusion, another blood sample was drawn and participants
received a beverage containing intrinsically l-[1-13C]-phenylalanine–
labeled protein (t = 0 min). Blood samples were collected at various
time points after protein ingestion. Blood samples were collected in
EDTA-containing tubes and centrifuged at 1000 × g for 10 min at
4◦C. Aliquots of plasma were frozen in liquid nitrogen and stored
at −80◦C.
Intrinsically labeled protein
Intrinsically l-[1-13C]-phenylalanine–labeled bovine milk protein was
produced by infusing l-[1-13C]-phenylalanine (420 μmol/min) into
lactating Holstein dairy cows as described previously (52–54). Milk was
obtained at each milking during and for 24 h following the infusion
and stored at −40◦C until further processing. Milk was fractionated
into a casein and a whey protein concentrate. First, milk was heated
to 50◦C and skimmed using a cream separator. The skimmed milk
was microfiltrated using a membrane with a pore size of 1.4 μm at
50◦C to remove microbes. The permeate was filtrated over a 0.2-μm
membrane to separate casein micelles (retentate) from soluble whey
proteins (permeate) at 55◦C. The casein micelles were concentrated,
diafiltrated with reverse osmosis (RO) water, and further concentrated
to ∼14% dry matter (containing 90% protein). The concentrated
casein solution was pasteurized and stored at −20◦C until further use.
The whey proteins were cooled and concentrated by means of a 10-
kDa membrane. The retentate was diafiltrated with RO water and
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concentrated to an end concentration of ∼5.5% dry matter (containing
96% protein). The whey protein concentrate was sterile filtrated and
freeze-dried. For the production of milk protein concentrate, milk was
heated to 55◦C and skimmed using a centrifuge. The skimmed milk
was pasteurized at 75◦C for 20 s. The skimmed milk was ultrafiltrated
and diafiltrated with RO water using a membrane with a pore size of
20 kDa at 10◦C. The permeate was concentrated to ∼18% dry matter
(containing ∼80% protein) and spray dried. All protein batches met the
chemical and microbiological specifications for human consumption.
The amount of protein powder consumed was adjusted for its protein
content such that the desired amount of protein was consumed by the
participants. The mean enrichment of the intrinsically labeled protein
was 33.3 ± 9.6 mole percent excess (MPE).
Calculations
The ingestion of intrinsically l-[1-13C]-phenylalanine–labeled protein,
intravenous infusion of l-[ring-2H5]-phenylalanine, and frequent blood
sampling were applied to assess dietary protein digestion and amino
acid absorption kinetics. Total and exogenous phenylalanine rate
of appearance (Ra) and plasma availability of dietary protein–
derived phenylalanine (i.e., the fraction of dietary protein–derived
phenylalanine that appeared in the circulation) were calculated using









Total Ra × Epo (t) +
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× BM × 100 (3)
where Fiv is the intravenous l-[ring-2H5]-phenylalanine tracer infusion
rate (μmol · kg−1 · min−1), pV (0.125 L/kg) is the distribution
volume, C(t) is the mean plasma phenylalanine concentration between
2 consecutive time points, dEiv/dt is the time-dependent change in
plasma l-[ring-2H5]-phenylalanine enrichment, and Eiv(t) is the mean
plasma l-[ring-2H5]-phenylalanine enrichment between 2 consecutive
time points. Exogenous Ra represents the rate at which dietary protein–
derived phenylalanine enters the circulation, which is a proxy for dietary
protein digestion and amino acid absorption. Epo(t) is the mean plasma
l-[1-13C]-phenylalanine enrichment between 2 consecutive time points,
dEpo/dt is the time-dependent change in plasma l-[1-13C]-phenylalanine
enrichment, and Eprotein is the l-[1-13C]-phenylalanine enrichment of
the dietary protein. AUCExogenous Ra represents the AUC of exogenous
Ra, Pheprotein is the amount of dietary phenylalanine ingested (μmol),
and BM is the participant’s body mass. For each batch of protein
the phenylalanine content was determined using GC-MS. The average
phenylalanine content was 228 μmol/g for whey protein, 317 μmol/g
for casein, and 259 μmol/g for milk protein. Plasma phenylalanine
availability was calculated for every hour after protein ingestion and
presented as cumulative over time. Plasma phenylalanine availability in
percentages was multiplied by the dose of protein ingested to obtain
the estimated plasma amino acid availability in grams. This calculation
assumes that dietary protein–derived phenylalanine is representative for
all essential and nonessential amino acids.
Statistical analysis
Data are expressed as means ± SDs (tables and text) or means ± SEMs
(graphs). Differences in participants’ characteristics, peak and time-
to-peak exogenous appearance rates, and plasma appearance over the
0–5-h postprandial period between protein types (whey, casein, milk)
or between protein doses (T1, T2, T3) were assessed using 1-factor
ANOVA followed by post hoc analysis with Bonferroni correction to
locate the differences. Differences in participants’ characteristics, peak
and time-to-peak exogenous appearance rates, and plasma appearance
over the 0–5-h postprandial period between young and older individuals
were assessed using independent 2-sample t tests. For all comparisons,
differences in dietary protein digestion and absorption kinetics
and cumulative plasma amino acid appearance were assessed using
2-factor repeated-measures ANOVA followed by post hoc analy-
sis with Bonferroni correction. Statistical significance was set at
P < 0.05. All calculations were performed using IBM SPSS Statistics
version 25.
Results
The complete dataset of 602 participants showed that 50%
± 14% of dietary protein–derived phenylalanine appeared
in the circulation during the 5-h postprandial period. We
subsequently assessed whether the type of protein, protein dose,
or age affected dietary protein digestion and absorption kinetics
and, as such, impacted the amount of dietary protein–derived
phenylalanine released into the circulation.
Type of protein
Appearance rates of dietary protein–derived phenylalanine in
the circulation rapidly increased following protein ingestion
(P-time < 0.001), with marked differences in phenylalanine
kinetics between whey, casein, and milk protein ingestion
(P-interaction < 0.001; Figure 1A). Exogenous phenylalanine
appearance rates increased to a peak of 0.35 ± 0.09 μmol · kg−1
· min−1 at 49 ± 20 min after whey protein ingestion compared
with 0.25 ± 0.10 μmol · kg−1 · min−1 at 96 ± 72 min after casein
ingestion (P < 0.001 for both peak and time-to-peak; Table 1).
The ingestion of milk protein resulted in intermediate peak
exogenous phenylalanine appearance rates (0.29 ± 0.10 μmol
· kg−1 · min−1), with the time-to-peak being similar to casein
ingestion (101 ± 55 min).
The cumulative increase over time in the fraction of dietary
protein–derived phenylalanine that appeared in the circulation
was higher after the ingestion of whey and milk protein
when compared with casein ingestion (P-interaction < 0.001;
Figure 1B). Moreover, milk protein ingestion resulted in lower
plasma phenylalanine appearance during the first 2 h, similar
plasma phenylalanine appearance during 3–4 h, and higher
plasma phenylalanine appearance after 5 h when compared
with whey protein ingestion. Over the entire 5-h postprandial
period, the ingestion of casein, whey, and milk protein
resulted in a lower (45% ± 11%), intermediate (57% ±
10%), and greater (65% ± 13%) fraction of dietary protein–
derived phenylalanine appearing in the circulation, respectively
(P < 0.001; Figure 1B, insert).
Whey protein dose
We observed a dose–response relation after graded intakes
(relative to BM) of whey protein (P-interaction < 0.001;
Figure 2A), with exogenous phenylalanine appearance rates
reaching peak values of 0.28 ± 0.07, 0.38 ± 0.06, and
0.43 ± 0.08 μmol · kg−1 · min−1 after consuming the lower,
medium, and higher dose of whey protein (P < 0.001; Table 2).
Peak exogenous phenylalanine appearance rates were reached
at 45 ± 22 min, 43 ± 11 min, and 50 ± 20 min after
ingesting the lower, medium, and highest whey protein dose,
respectively, with no significant differences between doses
(P = 0.382).







niversity of Exeter user on 02 M
arch 2020
FIGURE 1 Rate of appearance of dietary protein–derived pheny-
lalanine (A) as well as cumulative plasma phenylalanine appearance
over time in percentages (B) and over the entire 0–5-h postprandial
period (B, insert) in participants who consumed 23 ± 5, 24 ± 7,
and 26 ± 11 g intrinsically labeled whey (n = 137), casein (n = 393),
and milk (n = 72) protein, respectively. Values are means ± SEMs.
Labeled means without a common letter differ, P < 0.05. Ra, rate of
appearance.
The cumulative increase over time in the fraction of
dietary protein–derived phenylalanine that appeared in the
circulation differed between the whey protein doses (P-
interaction < 0.001), with a greater fraction appearing after
ingesting the medium and larger whey protein doses when
compared with the lower whey protein dose from 3 h onwards
(Figure 2B). Over the 5-h postprandial period, 51% ± 10%,
57% ± 9%, and 61% ± 7% of the dietary protein–derived
phenylalanine had appeared in the circulation following the
ingestion of the smaller, intermediate, and greater dose of whey
protein, respectively (P = 0.001; Figure 2B, insert). When
calculating the estimated plasma amino acid availability in
grams we observed that a greater amount of dietary protein–
derived amino acids had appeared in the circulation after
ingesting the intermediate and greater doses of whey protein
when compared with the smaller dose from 2 h onwards (P-
interaction < 0.001; Figure 2C). Over the 5-h postprandial
period, 11.4 ± 3.0 g, 13.4 ± 3.0 g, and 14.4 ± 1.8 g of
the dietary protein–derived amino acids had appeared in the
circulation after ingesting the smaller, intermediate, and greater
dose of whey protein, respectively (P < 0.001; Figure 2C, insert).
FIGURE 2 Rate of appearance of dietary protein–derived pheny-
lalanine (A) and cumulative plasma phenylalanine appearance over
time in percentages (B), and estimated amount of dietary protein–
derived amino acids that appeared in the circulation in grams (C)
in participants who consumed intrinsically labeled whey protein
(n = 76) by tertile of protein dose in grams per kilogram of BM
(0.23 ± 0.04 vs. 0.29 ± 0.01 vs. 0.35 ± 0.04 g/kg BM). Values are
means ± SEMs. Labeled means without a common letter differ,
P < 0.05. BM, body mass; Ra, rate of appearance; T, tertile.
Casein dose
We subsequently assessed the dose–response relation for casein
(Figure 3) and observed a stepwise increase in exogenous
phenylalanine appearance rates with increasing intakes (relative
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FIGURE 3 Rate of appearance of dietary protein–derived
phenylalanine (A) and cumulative plasma phenylalanine appearance
over time in percentages (B) and estimated amount of dietary
protein–derived amino acids that appeared in the circulation in
grams (C) in participants who consumed intrinsically labeled casein
(n = 359) by tertile of protein dose in grams per kilogram of BM
(0.24 ± 0.01 vs. 0.28 ± 0.02 vs. 0.44 ± 0.07 g/kg BM). Values are
means ± SEMs. Labeled means without a common letter differ,
P < 0.05. BM, body mass; Ra, rate of appearance; T, tertile.
to BM) of casein (P-interaction < 0.001; Figure 3A). Peak ex-
ogenous phenylalanine appearance rates averaged 0.23 ± 0.09,
0.26 ± 0.10, and 0.29 ± 0.10 μmol · kg−1 · min−1 for the
smaller, intermediate, and greater dose of casein, respectively
(P < 0.001; Table 3). Time-to-peak was similar between the
smaller (91 ± 73 min) and intermediate (87 ± 66 min) dose,
but it took longer to reach peak exogenous phenylalanine
appearance rates after ingesting the higher dose of casein
(116 ± 77 min; P = 0.004).
The cumulative increase over time in the fraction of dietary
protein–derived phenylalanine that entered the circulation
differed between the ingestion of different amounts of casein (P-
interaction = 0.003; Figure 3B). Casein-derived phenylalanine
availability did not differ between the smaller and intermediate
dose, but was lower after ingesting the larger dose of casein
at all time points. Over the 5-h postprandial period, 47% ±
12% and 47% ± 10% of dietary protein–derived phenylalanine
appeared in the circulation after the ingestion of the smaller
and intermediate protein doses, with only 41% ± 11% of the
larger casein dose entering the circulation (P < 0.001; Figure 3B,
insert). Despite the lower relative fraction, an absolute greater
estimated amount of dietary protein–derived amino acids had
appeared in the circulation after ingesting the greater dose
when compared with the small and intermediate doses of
casein (P-interaction < 0.001; Figure 3C). Over the entire
5-h postprandial period, 9.4 ± 2.4 g, 9.9 ± 2.1 g, and
13.0 ± 3.6 g amino acids were calculated to have appeared
in the circulation 5 h after ingesting the smaller, intermediate,
and greater dose of casein, respectively (P < 0.001; Figure 3C,
insert).
Age
Last, we investigated whether age affects dietary protein diges-
tion and absorption kinetics and the subsequent appearance
of dietary protein–derived phenylalanine in the circulation.
We included data from 4 studies from our laboratory in
which we compared postprandial protein handling in both
young and older individuals. These 4 studies used casein
as the type of protein consumed. Figure 4 shows com-
promised protein digestion and absorption kinetics in older
when compared with young individuals (P-age = 0.001, P-
interaction = 0.149). Peak exogenous phenylalanine appear-
ance rates (0.28 ± 0.10 vs. 0.25 ± 0.11 μmol · kg−1 · min−1)
and time-to-peak (96 ± 70 vs. 84 ± 72 min) did not differ
between young and older individuals (P = 0.151 and P = 0.272,
respectively; Table 4). However, the fraction of dietary protein–
derived phenylalanine appearing in the circulation was signifi-
cantly lower in the older compared with the young individuals
(P-interaction < 0.001; Figure 4B). Over the 5-h postprandial
period, 45% ± 10% of dietary protein–derived phenylalanine
had appeared in the circulation in the older individuals, which
was significantly lower compared with the young individuals
(51% ± 14%; P = 0.001; Figure 4B, insert). This translated to
an estimated 9.6 ± 2.2 g compared with 10.9 ± 2.7 g dietary
protein–derived amino acids appearing in the circulation during
the 5-h postprandial period in the older versus the young
individuals, respectively (P = 0.001; Figure 4C). Similar results
were obtained when excluding the co-interventions exercise,
carbohydrate co-ingestion, and (local) insulin administration.
Discussion
Our analysis combined data from 18 RCTs with >600
participants and showed that ∼50% of dietary protein–
derived phenylalanine appeared in the circulation within a 5-h
postprandial period without taking into account the ingested
protein amount or type. This suggests that ≥50% of dietary
protein is effectively digested and absorbed and becomes
available for peripheral tissues such as skeletal muscle, while
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FIGURE 4 Rate of appearance of dietary protein–derived phenylalanine (A) and cumulative plasma phenylalanine appearance over time in
percentages (B) and estimated amount of dietary protein–derived amino acids that appeared in the circulation in grams (C) after the ingestion of
22 ± 5 g intrinsically labeled casein in young (n = 82) and older (n = 83) men. Values are means ± SEMs. ∗Different from young men, P < 0.05.
Ra, rate of appearance; T, tertile.
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the other 50% of dietary protein is either not (yet) digested and
absorbed, or retained and taken up by splanchnic tissues such as
the gut and liver. Postprandial plasma phenylalanine availability
gradually increased over time and did not yet reach a plateau at
5 h, suggesting that more dietary protein–derived phenylalanine
will appear in the circulation beyond the 5-h postprandial
period. Indeed, our studies have shown greater postprandial
plasma phenylalanine availability when the postprandial period
was extended to 6 h (20, 56) or 7.5 h (41, 43, 44). Interestingly,
we observed a large variation in the fraction of dietary protein–
derived phenylalanine released into the circulation, ranging
between 25% and 80% of the ingested dietary protein. As such,
we investigated whether this variability can be explained, at
least partly, by the type of protein provided, the dose of protein
ingested, and/or the age of the participant.
In line with the current literature (3, 20), we showed that
whey protein is more rapidly digested and absorbed when
compared with micellar casein. Few studies have assessed
protein digestion and absorption kinetics after ingesting intact
bovine milk protein, which is composed of both whey protein
and micellar casein in a ratio of 20:80 (29, 56, 57). Here, we
show that ingested milk protein concentrate is more rapidly
digested and absorbed when compared with micellar casein,
but more slowly digested and absorbed when compared with
whey protein. Interestingly, when the entire 5-h postprandial
period was taken into account, a greater fraction of dietary
protein–derived phenylalanine appeared in the circulation after
milk protein ingestion (65% ± 13%) when compared with
whey protein (57% ± 10%) or casein (45% ± 11%) ingestion.
These findings indicate that ingestion of a dietary protein that
is most rapidly digested and absorbed, such as whey protein,
does not necessarily result in the greatest plasma availability of
dietary protein–derived phenylalanine. In fact, it has previously
been suggested that the more rapid digestion of soy protein
when compared with milk protein resulted in more amino
acids being directed towards deamination pathways and liver
protein synthesis (58). However, the differences in amino acid
composition and Digestible Indispensable Amino Acid Score
between protein types may also impact splanchnic amino acid
uptake and subsequent plasma amino acid availability. Overall,
it is evident that the type of ingested protein is one of the
main factors that modulate postprandial availability of dietary
protein–derived phenylalanine in the circulation.
We subsequently evaluated whether the ingestion of various
dosages of both whey protein and micellar casein affected
dietary protein digestion and phenylalanine absorption kinetics
and subsequent increase in dietary protein–derived phenylala-
nine availability in the circulation. With increasing doses of
whey protein, we observed a stepwise increase in protein
digestion and phenylalanine absorption rates (Figure 2A).
Higher postprandial release rates of dietary protein–derived
phenylalanine were accompanied by a greater availability of
dietary protein–derived phenylalanine in the circulation. After
consuming the higher dose of whey protein, 61% ± 7% of
the dietary protein–derived phenylalanine had appeared in the
circulation throughout the 5-h postprandial period, compared
with 51% ± 10% after ingesting the lower whey protein dose.
This translates to an estimated amount of 14.4 ± 1.8 ver-
sus 11.4 ± 3.0 g amino acids that appeared in the circulation
over 5 h after ingesting the high- versus the low-protein dose,
respectively. For the casein dose–response, we also observed
a stepwise increase in appearance rates of dietary protein–
derived phenylalanine (Figure 3A). However, higher rates of
protein digestion and phenylalanine absorption after the higher
protein dose did not result in greater postprandial plasma
phenylalanine availability (Figure 3B). After consuming the
higher doses of casein, merely 41% ± 11% of protein-derived
phenylalanine had appeared in the circulation, compared with
47% ± 12% after consuming the lower protein dose. Nonethe-
less, a greater absolute amount of dietary protein–derived amino
acids appeared in the circulation after consuming the higher
(13.0 ± 3.6 g) compared with the lower (9.4 ± 2.4 g) casein
dose. These findings are in line with recent work from our
laboratory assessing the milk protein dose–response (15–30–
45 g) during recovery from resistance-type exercise in older
men (56). This study showed that lower relative but greater
absolute amounts of protein-derived amino acids appeared in
the circulation after consuming a higher dose of milk protein
throughout a 6-h postprandial period (56). The discrepancy
between whey protein and micellar casein in the current study
may be attributed to the duration of the postprandial period.
Whey protein at the various ingested doses is almost completely
digested and absorbed (i.e., exogenous Ra at 5 h is close to zero),
whereas casein does not seem completely digested and absorbed
yet within the 5-h postprandial period. As such, casein-derived
phenylalanine may likely continue to appear in the circulation
after the 5-h postprandial period. Overall, our data indicate that
the availability of dietary protein–derived phenylalanine in the
circulation increases with increasing the ingested protein dose
and also depends on the duration of the postprandial period
that is assessed.
To define the impact of age on dietary protein digestion
and phenylalanine absorption kinetics and the subsequent
availability of dietary protein–derived phenylalanine in the
circulation, we combined data from 4 RCTs that compared
young and older individuals within the same study (27, 32,
35, 42). Peak protein digestion and phenylalanine absorption
rates were similar between young and older men. However,
protein digestion and phenylalanine absorption rates declined
more rapidly in older when compared with the young
individuals, which resulted in a lower postprandial availability
of dietary protein–derived phenylalanine in the circulation.
While 51% ± 14% of dietary protein–derived phenylalanine
had appeared in the circulation over the 5-h postprandial period
in the young men, 45% ± 10% appeared in the circulation
in older men. This translates to an estimated amount of
10.9 ± 2.7 g when compared with 9.6 ± 2.2 g of dietary
protein–derived amino acids (of the ∼22 g ingested) that
appeared in the circulation over the 5-h postprandial period in
young compared with older men, respectively. Such a seemingly
small impairment in dietary protein digestion and absorption
with each meal at an older age could have a substantial impact
on muscle mass maintenance in the long term. Data from the
current study suggest that ingesting a larger protein dose and
selecting milk protein as the preferred protein type may result
in greater postprandial plasma phenylalanine availability, which
may compensate for the lower postprandial phenylalanine
availability at a more advanced age.
A potential limitation of this study is that mainly men were
included in the analysis. However, we have recently shown
that dietary protein digestion and phenylalanine absorption
kinetics and the subsequent postprandial plasma phenylalanine
availability do not differ between women and men (59).
Another limitation is that we do not have data on habitual
protein intake amounts prior to all experiments. We have
previously shown that 2 wk of habituation to a lower protein
intake (i.e., 0.7 g · kg−1 · d−1) compared with a higher protein
intake (i.e., 1.5 g · kg−1 · d−1) augments the postprandial
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availability of dietary protein–derived phenylalanine in the
circulation (21). Although we expect a low(er) variation in
habitual protein intake amounts between the participants in the
included studies, determining habitual protein intake amounts
may need to be considered in future studies.
In conclusion, protein type, protein dose, and age modulate
dietary protein digestion and phenylalanine absorption kinetics
and, as such, the postprandial release of dietary protein–derived
phenylalanine into the circulation in vivo in humans. Older age
is accompanied by an attenuated postprandial release of dietary
protein–derived phenylalanine into the circulation.
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